- About Us
- Guidelines
-
The Author ensures that the research has been conducted responsibly and ethically with adherence to all relevant regulations. read more..
- For Authors
- For Reviewer
- Manuscript Guidelines
- Membership
-
- Journals
- Reprints
- e-Books
- Videos
- Indexing
- Contact Us
COVID-19
- Submissions
Abstract
Cohesive Journal of Microbiology & Infectious Disease
Comments of Clinical and Microbiological Experience with Daptomycin in Chronic Osteomyelitis Treatment
-
Open or Close Marcano-Lozada Marcel
1 Angios Vascular Center & Wound Clinic, Venezuela
2 JM Vargas School of Medicine, Universidad Central de Venezuela, Venezuela
*Corresponding author: Marcel Marcano-Lozada, MD, Microbiology Department, Medical Doctor, Medical Microbiology Specialist, Medical Microbiology Unit, Angios Vascular Center & Wound Clinic, “J.M. Vargas” School of Medicine, Universidad Central de Venezuela, Caracas, Venezuela
Submission: May 25, 2018; Published: October 24, 2018
ISSN: 2578-0190 Volume2 Issue2
Abstract
In the last decade, the use of daptomycin (alone or in combination) for the treatment of Chronic Osteomyelitis (CO) due to Staphylococcus aureus shows successful outcomes in the most complicated patients, and emerges as an option to be consider for elderly patients with several associated comorbidities.
Editor In Chief
.jpg)
Signup for Newsletter
Quick Links
Editorial Board Registrations
Submit your Article
Best Paper of the Volume
Reprints
Refer a Friend
Advertise With UsOur Recent Edition
.jpg)
Top Editors
.jpg)
.bmp)
.jpg)
.png)
.jpg)
.png)
.png)
.png)
Financial Support
Sponsors
Latest e-Books
Latest Video
a Creative Commons Attribution 4.0 International License. Based on a work at www.crimsonpublishers.com.
Best viewed in 
| Above IE 9.0 version